Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1975 Oct 25;4(5990):203–204. doi: 10.1136/bmj.4.5990.203

Observations on the systemic effect of topical clobetasol propionate (Dermovate).

J A Carruthers, P J August, R C Staughton
PMCID: PMC1674965  PMID: 1191997

Abstract

Topical application of clobetasol propionate in a strength of 0-05% in cream or ointment (Dermovate) suppressed the hypothalamic-pituitary-adrenal axis in both normal people and patients with diseased skin. In normal people the 9 am serum cortisol level was suppressed when between 45 and 90 g was applied weekly. Insulin stress test results in patients with diseased skin showed an abnormally small response after long-term application of similar amounts. We conclude that long-term administration should be restricted to less than 50 g a week.

Full text

PDF
203

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker H., Ryan T. J. Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol. 1968 Dec;80(12):771–793. doi: 10.1111/j.1365-2133.1968.tb11947.x. [DOI] [PubMed] [Google Scholar]
  2. Boxley J. D., Dawber R. P., Summerly R. Generalized pustular psoriasis on withdrawal of clobetasol propionate ointment. Br Med J. 1975 May 3;2(5965):255–256. doi: 10.1136/bmj.2.5965.255-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Feiwel M., Kelly W. F. Letter: Adrenal unresponsiveness associated with clobetasol propionate. Lancet. 1974 Jul 13;2(7872):112–113. doi: 10.1016/s0140-6736(74)91685-7. [DOI] [PubMed] [Google Scholar]
  4. LANDON J., WYNN V., JAMES V. H. THE ADRENOCORTICAL RESPONSE TO INSULIN-INDUCED HYPOGLYCAEMIA. J Endocrinol. 1963 Nov;27:183–192. doi: 10.1677/joe.0.0270183. [DOI] [PubMed] [Google Scholar]
  5. Murphy B. E. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. J Clin Endocrinol Metab. 1967 Jul;27(7):973–990. doi: 10.1210/jcem-27-7-973. [DOI] [PubMed] [Google Scholar]
  6. Ortega E., Burdick K. H., Segre E. J. Letter: Adrenal suppression by clobetasol propionate. Lancet. 1975 May 24;1(7917):1200–1200. doi: 10.1016/s0140-6736(75)93194-3. [DOI] [PubMed] [Google Scholar]
  7. Sparkes C. G., Wilson L. The clinical evaluation of a new topical corticosteroid, clobetasol propionate. An international controlled trial. Br J Dermatol. 1974 Feb;90(2):197–203. doi: 10.1111/j.1365-2133.1974.tb06385.x. [DOI] [PubMed] [Google Scholar]
  8. Staughton R. C., August P. J. Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate. Br Med J. 1975 May 24;2(5968):419–421. doi: 10.1136/bmj.2.5968.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Tan R. S. Pustular psoriasis with adrenal suppression following topical corticosteroids. Proc R Soc Med. 1974 Aug;67(8):719–720. [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES